Once the program is complete, Beneo will have increased its capacity by more than 40%.
Beneo production site in Oreye, Belgium
Beneo has announced a multi-million dollar investment program for the coming years to expand the capacity of its prebiotic chicory root fiber productions facilities in Pemuco, Chile, and Oreye, Belgium. Once the program is complete, Beneo will have increased its capacity by more than 40%, which will allow the company to meet increasing customer demand and drive growth within the market. Work on both production sites will begin in 2022, with an initial investment of more than $33 million.
“Beneo's chicory root fibers meet key consumer needs of today and we are convinced that they will continue to play a central role in healthy nutrition in the future.,” said Christoph Boettger, member of Beneo’s executive board, in a press release. “With increased capacity, BENEO continues to offer a secure supply to its customers and partners worldwide."
With production sites located in both the Northern and Southern hemispheres, Beneo offers flexibility and a secure supply of chicory roof fiber to customers throughout the world.
“As announced previously, in summer 2022 a second refinery line in Pemuco will already increase the production capacity significantly. But we won’t stop there. The recent investment decision will ensure that Beneo’s production capacity is further growing. On top of this capacity increase, CO2 emissions are being reduced. This means that the production site in Pemuco will be carbon neutral in a few years. Additionally, the site in Oreye will have reduced the specific energy consumption per ton of product by more than 50 percent by 2030,” Boettger added.
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.